• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

老年吸烟者的慢性阻塞性肺疾病风险表型:在全球慢性阻塞性肺疾病倡议组织(GLI)和慢性阻塞性肺疾病全球倡议(GOLD)定义的呼吸功能损害中的评估

COPD Risk Phenotypes in Older Smokers: Evaluation in GLI- and GOLD-Defined Respiratory Impairment.

作者信息

Bohadana Abraham, Wild Pascal, Rokach Ariel, Berg Assaf, Izbicki Gabriel

机构信息

Department of Medicine, Shaare Zedek Medical Center and Faculty of Medicine, Respiratory Research Unit, Pulmonary Institute, Hebrew University of Jerusalem, 12, Bayit Street, 91031, Jerusalem, Israel.

PW Statistical Consulting, 54000, Laxou, France.

出版信息

Lung. 2024 Nov 27;203(1):3. doi: 10.1007/s00408-024-00757-4.

DOI:10.1007/s00408-024-00757-4
PMID:39601892
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11602840/
Abstract

PURPOSE

In aging populations, the Global Initiative for Obstructive Lung Disease (GOLD) spirometry threshold may misclassify normal spirometry as airflow limitation. The Global Lung Initiative (GLI) method provides age-adjusted criteria. We investigated how the use of GOLD or GLI thresholds in an algorithm affects the classification of elderly smokers into COPD risk phenotypes.

METHODS

Using a modified COPDGene algorithm, including exposure, symptoms, and abnormal spirometry, 200 smokers aged 60 years and older were classified into 4 mutually exclusive phenotypes: Phenotype A (no symptoms, normal spirometry; reference), Phenotype B (symptoms, normal spirometry; possible COPD), Phenotype C (no symptoms, abnormal spirometry; possible COPD), and Phenotype D (symptoms, abnormal spirometry; probable COPD). Abnormal spirometry was defined according to the GOLD or GLI criteria. A comparison was made between the GOLD- and GLI-defined phenotypes.

RESULTS

Using GLI criteria/cut-offs, 18.5% (n = 37) had phenotype A (no COPD), 42% (n = 84) had phenotype B (possible COPD), 7.5% (n = 15) had phenotype C (possible COPD), and 32% (n = 64) had phenotype D (probable COPD). Using GOLD criteria cut-offs, 14.5% (n-29) had phenotype A (no COPD); 31% (n = 62) had phenotype B, 11.5% (n = 23) had phenotype C (probable COPD), and 43% (n = 86) had phenotype D (probable COPD). Eight smokers with GOLD phenotype C were reclassified as GLI phenotype A, while 22 with GOLD phenotype D were reclassified as GLI phenotype B. Smokers identified as ‟probable COPD" by GOLD alone (potential false positives) had better spirometry results than those identified as ‟probable COPD" by both GOLD and GLI.

CONCLUSION

The use of the GOLD threshold in an algorithm resulted in older smokers being classified into more severe COPD risk phenotypes compared to the GLI threshold. This suggests that GOLD may misclassify smokers with less affected phenotypes as having respiratory impairment, potentially leading to unnecessary and harmful treatments.

摘要

目的

在老龄化人群中,慢性阻塞性肺疾病全球倡议组织(GOLD)的肺活量测定阈值可能会将正常肺活量测定错误分类为气流受限。全球肺部倡议组织(GLI)的方法提供了年龄调整标准。我们研究了在一种算法中使用GOLD或GLI阈值如何影响老年吸烟者慢性阻塞性肺疾病(COPD)风险表型的分类。

方法

使用一种改良的COPDGene算法,包括暴露因素、症状和异常肺活量测定,将200名60岁及以上的吸烟者分为4种相互排斥的表型:表型A(无症状,肺活量测定正常;参照)、表型B(有症状,肺活量测定正常;可能患有COPD)、表型C(无症状,肺活量测定异常;可能患有COPD)和表型D(有症状,肺活量测定异常;很可能患有COPD)。异常肺活量测定根据GOLD或GLI标准定义。对GOLD和GLI定义的表型进行比较。

结果

使用GLI标准/临界值时,18.5%(n = 37)为表型A(无COPD),42%(n = 84)为表型B(可能患有COPD),7.5%(n = 15)为表型C(可能患有COPD),32%(n = 64)为表型D(很可能患有COPD)。使用GOLD标准临界值时,14.5%(n = 29)为表型A(无COPD);31%(n = 62)为表型B,11.5%(n = 23)为表型C(很可能患有COPD),43%(n = 86)为表型D(很可能患有COPD)。8名GOLD表型C的吸烟者被重新分类为GLI表型A,而22名GOLD表型D的吸烟者被重新分类为GLI表型B。仅被GOLD判定为“很可能患有COPD”(潜在假阳性)的吸烟者的肺活量测定结果优于被GOLD和GLI均判定为“很可能患有COPD”的吸烟者。

结论

与GLI阈值相比,在算法中使用GOLD阈值会使老年吸烟者被分类为更严重的COPD风险表型。这表明GOLD可能会将受影响较小表型的吸烟者错误分类为有呼吸功能损害,可能导致不必要且有害的治疗。

相似文献

1
COPD Risk Phenotypes in Older Smokers: Evaluation in GLI- and GOLD-Defined Respiratory Impairment.老年吸烟者的慢性阻塞性肺疾病风险表型:在全球慢性阻塞性肺疾病倡议组织(GLI)和慢性阻塞性肺疾病全球倡议(GOLD)定义的呼吸功能损害中的评估
Lung. 2024 Nov 27;203(1):3. doi: 10.1007/s00408-024-00757-4.
2
Phenotype of normal spirometry in an aging population.老年人群中正常肺功能测定的表型
Am J Respir Crit Care Med. 2015 Oct 1;192(7):817-25. doi: 10.1164/rccm.201503-0463OC.
3
Clinical Use of an Exposure, Symptom, and Spirometry Algorithm to Stratify Smokers into COPD Risk Phenotypes: A Case Finding Study Combined with Smoking Cessation Counseling.使用暴露、症状和肺量计算法对吸烟者进行慢性阻塞性肺疾病(COPD)风险表型分层的临床应用:一项结合戒烟咨询的病例发现研究
Chronic Obstr Pulm Dis. 2023 Jul 26;10(3):248-258. doi: 10.15326/jcopdf.2022.0368.
4
Implications of using the GLI-2012, GOLD and Australian COPD-X recommendations in assessing the severity of airflow limitation on spirometry among an Indigenous population with COPD: an Indigenous Australians perspective study.使用 GLI-2012、GOLD 和澳大利亚 COPD-X 建议评估 COPD 土著人群中肺功能气流受限严重程度的影响:一项澳大利亚土著人视角的研究。
BMJ Open Respir Res. 2021 Dec;8(1). doi: 10.1136/bmjresp-2021-001135.
5
Risk of COPD with obstruction in active smokers with normal spirometry and reduced diffusion capacity.肺活量测定正常但弥散功能降低的现吸烟者患慢性阻塞性肺疾病(COPD)伴气流受限的风险。
Eur Respir J. 2015 Dec;46(6):1589-1597. doi: 10.1183/13993003.02377-2014. Epub 2015 Nov 5.
6
Chronic obstructive pulmonary disease with mild airflow limitation: current knowledge and proposal for future research - a consensus document from six scientific societies.伴有轻度气流受限的慢性阻塞性肺疾病:当前认知与未来研究建议——六家科学学会的共识文件
Int J Chron Obstruct Pulmon Dis. 2017 Aug 29;12:2593-2610. doi: 10.2147/COPD.S132236. eCollection 2017.
7
Phenotype of Spirometric Impairment in an Aging Population.老年人群中肺量计损伤的表型
Am J Respir Crit Care Med. 2016 Apr 1;193(7):727-35. doi: 10.1164/rccm.201508-1603OC.
8
Spirometric Criteria for Chronic Obstructive Pulmonary Disease in Clinical Trials of Pharmacotherapy.药物治疗临床试验中慢性阻塞性肺疾病的肺量计标准
COPD. 2018 Feb;15(1):17-20. doi: 10.1080/15412555.2018.1424815.
9
Respiratory and Bronchitic Symptoms Predict Intention to Quit Smoking among Current Smokers with, and at Risk for, Chronic Obstructive Pulmonary Disease.呼吸和支气管症状可预测慢性阻塞性肺疾病患者及有慢性阻塞性肺疾病风险的当前吸烟者的戒烟意愿。
Ann Am Thorac Soc. 2016 Sep;13(9):1490-6. doi: 10.1513/AnnalsATS.201601-075OC.
10
Comparison of clinical features between non-smokers with COPD and smokers with COPD: a retrospective observational study.非吸烟慢性阻塞性肺疾病患者与吸烟慢性阻塞性肺疾病患者的临床特征比较:一项回顾性观察研究。
Int J Chron Obstruct Pulmon Dis. 2014;9:57-63. doi: 10.2147/COPD.S52416. Epub 2014 Jan 8.

引用本文的文献

1
LUNG Year in Review: 2024.《肺部年度回顾:2024》
Lung. 2025 Jan 22;203(1):29. doi: 10.1007/s00408-025-00785-8.

本文引用的文献

1
Application of the European Respiratory Society/American Thoracic Society Spirometry Standards and Race-Neutral Equations in the COPDGene Study.欧洲呼吸学会/美国胸科学会肺量计标准和种族中性方程在 COPDGene 研究中的应用。
Am J Respir Crit Care Med. 2024 Dec 1;210(11):1317-1328. doi: 10.1164/rccm.202311-2145OC.
2
Clinical Use of an Exposure, Symptom, and Spirometry Algorithm to Stratify Smokers into COPD Risk Phenotypes: A Case Finding Study Combined with Smoking Cessation Counseling.使用暴露、症状和肺量计算法对吸烟者进行慢性阻塞性肺疾病(COPD)风险表型分层的临床应用:一项结合戒烟咨询的病例发现研究
Chronic Obstr Pulm Dis. 2023 Jul 26;10(3):248-258. doi: 10.15326/jcopdf.2022.0368.
3
Towards the elimination of chronic obstructive pulmonary disease: a Lancet Commission.迈向消除慢性阻塞性肺疾病:柳叶刀委员会报告。
Lancet. 2022 Sep 17;400(10356):921-972. doi: 10.1016/S0140-6736(22)01273-9. Epub 2022 Sep 5.
4
Screening for Chronic Obstructive Pulmonary Disease: US Preventive Services Task Force Reaffirmation Recommendation Statement.慢性阻塞性肺疾病筛查:美国预防服务工作组重新确认推荐声明。
JAMA. 2022 May 10;327(18):1806-1811. doi: 10.1001/jama.2022.5692.
5
Small Airways Disease, Biomarkers and COPD: Where are We?小气道疾病、生物标志物与 COPD:我们处于什么阶段?
Int J Chron Obstruct Pulmon Dis. 2021 Feb 18;16:351-365. doi: 10.2147/COPD.S280157. eCollection 2021.
6
COPD: A New Diagnostic Paradigm.慢性阻塞性肺疾病:一种新的诊断模式。
Chronic Obstr Pulm Dis. 2019 Nov;6(5):438-443. doi: 10.15326/jcopdf.6.5.2019.0172.
7
COPDGene 2019: Redefining the Diagnosis of Chronic Obstructive Pulmonary Disease.慢性阻塞性肺疾病基因研究(COPDGene)2019:重新定义慢性阻塞性肺疾病的诊断
Chronic Obstr Pulm Dis. 2019 Nov;6(5):384-399. doi: 10.15326/jcopdf.6.5.2019.0149.
8
Standardization of Spirometry 2019 Update. An Official American Thoracic Society and European Respiratory Society Technical Statement.肺功能测定标准化 2019 修订版。美国胸科学会和欧洲呼吸学会官方技术声明。
Am J Respir Crit Care Med. 2019 Oct 15;200(8):e70-e88. doi: 10.1164/rccm.201908-1590ST.
9
Trajectory and mortality of preserved ratio impaired spirometry: the Rotterdam Study.肺活量测定值保存比例受损的轨迹与死亡率:鹿特丹研究
Eur Respir J. 2020 Jan 2;55(1). doi: 10.1183/13993003.01217-2019. Print 2020 Jan.
10
Discriminative Accuracy of FEV1:FVC Thresholds for COPD-Related Hospitalization and Mortality.FEV1:FVC 阈值对 COPD 相关住院和死亡的鉴别准确性。
JAMA. 2019 Jun 25;321(24):2438-2447. doi: 10.1001/jama.2019.7233.